Get started
Author

Kyle Lien

Major adverse cardiovascular events after teclistamab in relapsed refractory multiple myeloma: A multicenter study from the u.s. multiple myeloma immunotherapy consortium.
2025 · Dae Hyun Lee, Saurabh Zanwar, et al. · Blood · 1
Incidence and outcome of pulmonary hypertension in myelofibrosis.
2025 · Alexis Behne Sharma, Elicia Wang, et al. · Journal of Clinical Oncology · 1
PDF
A Cohort Study of the Effectiveness of Trastuzumab Deruxtecan for Treating Metastatic Progressive HER2-Positive Breast Cancer
2026 · Ameer Basta, Kyle Lien, et al. · Clinical Breast Cancer
Real-world prevalence and outcome of elevated right ventricular systolic pressure in myelofibrosis
2026 · Alexis Behne Sharma, Elicia Wang, et al. · Cardio-Oncology
A Real-World Single-Center Cohort Study on the Tolerability of Trastuzumab Deruxtecan for HER2+ Metastatic Breast Cancer
2025 · Ameer Basta, Kyle Lien, et al. · Oncology
Abstract P2-08-04: A Cohort Study of the effectiveness and tolerability of Trastuzumab Deruxtecan For The Treatment of Metastatic or Locally Advanced HER2-positive Breast Cancer
2025 · Ameer Basta, Kyle Lien, et al. · Clinical Cancer Research
160: Machine Learning Prediction of Stage and Survival Using Cancer Stemness-related Isoform Expression in Gastric Adenocarcinoma
2025 · Yifan Liang, Kyle Lien, et al. · Gastroenterology
SCF FBXL5 ubiquitin ligase regulates stability of von-Hippel Lindau protein and the HIF1α-dependent response to hypoxia
2024 · Adarsh K Mayank, Vijaya Pandey, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
A Rare Presentation of Drug-Induced Autoimmune Hepatitis and the Role of Male Enhancement Supplements
2024 · Juan Enciso, Ruhi Vasavada-Patel, et al. · Cureus
PDF
Works count: 9
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type